WO2001087303A1 - Preparation liquide aqueuse - Google Patents
Preparation liquide aqueuse Download PDFInfo
- Publication number
- WO2001087303A1 WO2001087303A1 PCT/JP2001/004083 JP0104083W WO0187303A1 WO 2001087303 A1 WO2001087303 A1 WO 2001087303A1 JP 0104083 W JP0104083 W JP 0104083W WO 0187303 A1 WO0187303 A1 WO 0187303A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pranoprofen
- pharmacologically acceptable
- aqueous solution
- sulfa drug
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001583771A JP4754149B2 (ja) | 2000-05-17 | 2001-05-16 | 水性液剤 |
EP01932087A EP1283042B1 (en) | 2000-05-17 | 2001-05-16 | Aqueous liquid preparation of pranoprofen |
AU2001258754A AU2001258754A1 (en) | 2000-05-17 | 2001-05-16 | Aqueous liquid preparation |
DE60136064T DE60136064D1 (de) | 2000-05-17 | 2001-05-16 | Wässrige flüssige preparation von pranoprofen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000145640 | 2000-05-17 | ||
JP2000-145640 | 2000-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001087303A1 true WO2001087303A1 (fr) | 2001-11-22 |
Family
ID=18652118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/004083 WO2001087303A1 (fr) | 2000-05-17 | 2001-05-16 | Preparation liquide aqueuse |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1283042B1 (ja) |
JP (1) | JP4754149B2 (ja) |
KR (1) | KR100776579B1 (ja) |
CN (1) | CN1210028C (ja) |
AT (1) | ATE410164T1 (ja) |
AU (1) | AU2001258754A1 (ja) |
DE (1) | DE60136064D1 (ja) |
ES (1) | ES2310550T3 (ja) |
PT (1) | PT1283042E (ja) |
WO (1) | WO2001087303A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005239683A (ja) * | 2004-02-27 | 2005-09-08 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2005247803A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤及びその容器 |
JP2005247801A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
JP2006249054A (ja) * | 2004-03-29 | 2006-09-21 | Rohto Pharmaceut Co Ltd | プラノプロフェン含有医薬製剤 |
JP2008094779A (ja) * | 2006-10-13 | 2008-04-24 | Zeria Pharmaceut Co Ltd | 眼科用剤 |
JP2011098960A (ja) * | 2009-10-09 | 2011-05-19 | Rohto Pharmaceutical Co Ltd | 水性組成物 |
JP2013018797A (ja) * | 2012-10-31 | 2013-01-31 | Taisho Pharmaceutical Co Ltd | 眼科用剤 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2154876A (en) * | 1984-03-01 | 1985-09-18 | Yoshitomi Pharmaceutical | Ophthalmic solution |
JPH05186349A (ja) * | 1991-12-30 | 1993-07-27 | Teika Seiyaku Kk | プラノプロフェン点眼剤組成物 |
WO1996032941A1 (fr) * | 1995-04-20 | 1996-10-24 | Santen Pharmaceutical Co., Ltd. | Gouttes oculaires de pranoprofene renfermant un amine organique |
JPH10236951A (ja) * | 1996-12-27 | 1998-09-08 | Teika Seiyaku Kk | プラノプロフェン配合点眼剤 |
JPH10295777A (ja) * | 1997-04-28 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 安定な抗菌点眼剤 |
-
2001
- 2001-05-16 KR KR1020027015286A patent/KR100776579B1/ko active IP Right Grant
- 2001-05-16 CN CNB018096352A patent/CN1210028C/zh not_active Expired - Lifetime
- 2001-05-16 DE DE60136064T patent/DE60136064D1/de not_active Expired - Fee Related
- 2001-05-16 AU AU2001258754A patent/AU2001258754A1/en not_active Abandoned
- 2001-05-16 WO PCT/JP2001/004083 patent/WO2001087303A1/ja active Application Filing
- 2001-05-16 JP JP2001583771A patent/JP4754149B2/ja not_active Expired - Lifetime
- 2001-05-16 EP EP01932087A patent/EP1283042B1/en not_active Expired - Lifetime
- 2001-05-16 PT PT01932087T patent/PT1283042E/pt unknown
- 2001-05-16 AT AT01932087T patent/ATE410164T1/de not_active IP Right Cessation
- 2001-05-16 ES ES01932087T patent/ES2310550T3/es not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2154876A (en) * | 1984-03-01 | 1985-09-18 | Yoshitomi Pharmaceutical | Ophthalmic solution |
JPH05186349A (ja) * | 1991-12-30 | 1993-07-27 | Teika Seiyaku Kk | プラノプロフェン点眼剤組成物 |
WO1996032941A1 (fr) * | 1995-04-20 | 1996-10-24 | Santen Pharmaceutical Co., Ltd. | Gouttes oculaires de pranoprofene renfermant un amine organique |
JPH10236951A (ja) * | 1996-12-27 | 1998-09-08 | Teika Seiyaku Kk | プラノプロフェン配合点眼剤 |
JPH10295777A (ja) * | 1997-04-28 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 安定な抗菌点眼剤 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005239683A (ja) * | 2004-02-27 | 2005-09-08 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2005247803A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤及びその容器 |
JP2005247801A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
JP2006249054A (ja) * | 2004-03-29 | 2006-09-21 | Rohto Pharmaceut Co Ltd | プラノプロフェン含有医薬製剤 |
JP2008094779A (ja) * | 2006-10-13 | 2008-04-24 | Zeria Pharmaceut Co Ltd | 眼科用剤 |
JP2011098960A (ja) * | 2009-10-09 | 2011-05-19 | Rohto Pharmaceutical Co Ltd | 水性組成物 |
JP2015193634A (ja) * | 2009-10-09 | 2015-11-05 | ロート製薬株式会社 | 水性組成物 |
JP2013018797A (ja) * | 2012-10-31 | 2013-01-31 | Taisho Pharmaceutical Co Ltd | 眼科用剤 |
Also Published As
Publication number | Publication date |
---|---|
CN1438887A (zh) | 2003-08-27 |
EP1283042A1 (en) | 2003-02-12 |
CN1210028C (zh) | 2005-07-13 |
DE60136064D1 (de) | 2008-11-20 |
ES2310550T3 (es) | 2009-01-16 |
ATE410164T1 (de) | 2008-10-15 |
JP4754149B2 (ja) | 2011-08-24 |
KR20020094052A (ko) | 2002-12-16 |
EP1283042B1 (en) | 2008-10-08 |
KR100776579B1 (ko) | 2007-11-15 |
EP1283042A4 (en) | 2007-05-23 |
AU2001258754A1 (en) | 2001-11-26 |
PT1283042E (pt) | 2008-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4856392B2 (ja) | 防腐剤及びこれを含有する水性組成物 | |
JP4827374B2 (ja) | 局所投与のためのオロパタジン処方物 | |
JP3689123B2 (ja) | ビタミンa類可溶化水性点眼剤 | |
EP1782816B1 (en) | Water-based medicinal composition containing azithromycin and method of preparing the same | |
JP2011093923A (ja) | 点眼剤 | |
JP3142842B1 (ja) | 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法 | |
KR20010012521A (ko) | 방부 조성물 | |
JP6148957B2 (ja) | プラノプロフェン含有水性組成物 | |
JP5729109B2 (ja) | ソフトコンタクトレンズ用眼科組成物 | |
JP5176132B2 (ja) | 眼科用剤 | |
JP2003206241A (ja) | 眼科用剤 | |
JP6462201B2 (ja) | 水性眼科組成物 | |
WO2001087303A1 (fr) | Preparation liquide aqueuse | |
JP2002316926A (ja) | コンタクトレンズ用眼科用組成物及び眼刺激性の緩和方法 | |
JP5013735B2 (ja) | 眼粘膜適用製剤 | |
JP4442118B2 (ja) | 安定な点眼剤 | |
JP2011111425A (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
JP2005247795A (ja) | 安定な点眼剤 | |
JP5379186B2 (ja) | 防腐剤及びこれを含有する水性組成物 | |
JP2010043068A (ja) | 眼科用組成物及びなみだ目改善剤 | |
JP6224998B2 (ja) | オロパタジン含有水性組成物 | |
JP5623684B2 (ja) | 眼科用剤 | |
JP2013082682A (ja) | 亜塩素酸塩を含有する水性製剤 | |
JP2005075735A (ja) | オキシメタゾリン含有組成物 | |
JP4470393B2 (ja) | 安定である点眼剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 583771 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027015286 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018096352 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001932087 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027015286 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001932087 Country of ref document: EP |